Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Nevi”

288 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 288 results

Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Large-scale testing (Phase 3)WithdrawnNCT03070691
What this trial is testing

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Who this might be right for
Basal Cell Carcinoma
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT00049959
What this trial is testing

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

Who this might be right for
Basal Cell CarcinomaNevoid Basal Cell Carcinoma SyndromeGorlin Syndrome
QLT Inc.
Not applicableLooking for participantsNCT07621614
What this trial is testing

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Who this might be right for
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8+4 more
Children's Oncology Group 51
Testing effectiveness (Phase 2)Ended earlyNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 225
Not applicableNot Yet RecruitingNCT05637892
What this trial is testing

A Cohort Study of Hydatidiform Mole

Who this might be right for
Hydatidiform Mole
Women's Hospital School Of Medicine Zhejiang University 800
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Early research (Phase 1)Study completedNCT01463709
What this trial is testing

Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer

Who this might be right for
Basal Cell Carcinomas
UCSF Benioff Children's Hospital Oakland 4
Early research (Phase 1)Study completedNCT00687622
What this trial is testing

Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

Who this might be right for
Solid Tumours
GlaxoSmithKline 206
Early research (Phase 1)Study completedNCT01910181
What this trial is testing

Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 46
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Early research (Phase 1)Study completedNCT03467789
What this trial is testing

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Who this might be right for
Basal Cell CarcinomaBasal Cell Nevus Syndrome
Case Comprehensive Cancer Center 37
Not applicableStudy completedNCT04164550
What this trial is testing

Interpolated Flap Study

Who this might be right for
Skin Cancer, Non-MelanomaSkin Cancer MelanomaMohs Micrographic Surgery
University of Pennsylvania 170
Testing effectiveness (Phase 2)Ended earlyNCT01026051
What this trial is testing

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Who this might be right for
Stage III MelanomaStage IV Melanoma
Mannkind Corporation 5
Not applicableLooking for participantsNCT06330350
What this trial is testing

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling

Who this might be right for
Quality of LifeIchthyosisPalmoplantar Keratoses+7 more
Maastricht University Medical Center 25
Not applicableStudy completedNCT04705168
What this trial is testing

Study of the Nevisense Device to Assess Atypical Skin Lesions

Who this might be right for
NevusMultiple NeviLarge Acquired Nevi+1 more
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Study completedNCT04544748
What this trial is testing

GNR-051 in Subjects With Advanced Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma
AO GENERIUM 48
Early research (Phase 1)Looking for participantsNCT06332755
What this trial is testing

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)Head and Neck Squamous Cell Carcinoma(HNSCC)Renal Cell Carcinoma(RCC)+2 more
LG Chem 76
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Next Page